But the results keep coming, and a new lab study shows one potential mechanism by which ITCs may have an anti-cancer effect. Details of the study at Georgetown University Medical Center were published last month in the Journal of Medicinal Chemistry.
The findings centre on a protective molecule in our cells called p53. In a sizeable number of cancers (about half), something appears to have gone wrong with p53.US NEWS PAPER
The findings centre on a protective molecule in our cells called p53. In a sizeable number of cancers (about half), something appears to have gone wrong with p53.US NEWS PAPER
